5 shares related to Sputnik V vaccine in India

In this article, we have talked about 5 shares related to Sputnik V vaccine in India. We have covered listed companies involved in the manufacturing, and distribution of Sputnik V vaccines in India. 

Vaccine related shares in India

Hi, the Russian vaccine Sputnik V has made its entry but Dr. Reddy's says that they will be able to provide it fully by July and with that, they added that it would take 2 months to distribute in the major cities.

Till the time its domestic production is not started, they will provide it only to the private hospitals and with this Dr. Reddy's and Apollo hospitals have started the first phase of the vaccination in Hyderabad and Vishakhapatnam.

Sputnik V has been developed by Russian Direct Investment Fund and the efficacy has been set at 91.6% by the leading medical journal Lancet. And will be distributed by Dr. Reddy's in India and have said that they will give 250 million doses in the coming 8-10 months.

7 Best Image Editing Tools for Next-Level Bloggers

The Russian Ambassador to India, N Kardashian said that the production will be ramped up to 850 million doses a year and are planning to launch a single-dose vaccine named Sputnik Lite. We will now tell you about the shares linked to this vaccine and we have taken yesterday's market closing prices.

The first stock is Dr. Reddy's Laboratories, and they will distribute this vaccine throughout India. They have 6 manufacturing partners to perform this task smoothly and timely and have said that they will work with the govt and private authorities soo that the reach is maximized. From the time they have partnered with the Russian investment fund for the clinical trials and distribution.

Share Price

The company's share price increased by 18.63%, its ROE is 11.71%, and its OPM at 20.32%

Its sales have compounded by 4.125 in the last 5 years, its debt-equity ratio is at 0.17

Its PE ratio is 44.74 and a CAGR of 11.65% in the past 5 years

Panacea Biotech

The second company is Panacea Biotech, the news was announced on 5th Apr that they will produce 100 million doses and after that, its share price has jumped by 107.54%, it has manufacturing plants in Himachal Pradesh, Punjab, and Delhi and Adar Poonawalla had a 5.15% stake in this company and SII had 4.98% till March.

Share Price 

And yesterday a piece of news surfaced that, Adar Poonawalla sold all his stake of about 118 Crore to SII at a price of 373.85 per share. The company has recorded loss from FY12 till now. Their total debt is 641 Cr with a total sales of 582 Cr in the past 12 months It has compounded by 36.02% in the past 5 years.

Gland Pharma

The third company is Gland Pharma, a piece of news surfaced on 17th March that they will manufacture 252 million doses.

Share Price and Pharma stocks 2021

And from that time its share price has jumped by 10.55% and they have a total of 7 manufacturing units Its OPM is 37.61%, and ROE is 20.88 which is very good. The company has no debt with a PE ratio of 45.92. It was listed on 20th Nov 2020 with a listing gain of 86.67%

Shilpa Medicare

The fourth company is Shilpa Medicare, yesterday the news surfaced that its wholly-owned subsidiary Shilpa Biologics Pvt ltd has signed a contract with Dr Reddy's for 3 years for the manufacture of the vaccine According to this, they will manufacture 50 million doses in the first 12 months from their R&D cum manufacturing unit in Dharwad, Karnataka.

Share price

Its share price increased by 11.91% from yesterday, its ROE is 12.36%. Its OPM is 21.82%, debt-equity at 0.42, its sales have compounded by 8.14%, and its PE ratio is at 23.89 and its share price has compounded by 25 in the past 5 years

Apollo Hospitals

The fifth company is Apollo Hospitals, and they are collaborating with Dr Reddy's to ramp up the vaccination program. The first phase has been started in Hyderabad and is starting in Vishakhapatnam today.

Its PE ratio is 224.53, its ROE is 13.63%, OPM is at 10.12%, 5-year sales have compounded by 17% Its debt-equity ratio has been 1.02 and its stock price has compounded by 19% in the past 5 years.

We make all article for educational purposes so that we can deliver the right information. You can further do your own research, invest for the long term and make good returns.